Anand Srivastava
@asrivastavamd
Nephrologist and Clinical Researcher passionate about improving outcomes for our patients | @UICNeph | Opinions are my own.
ID: 1002349991506178048
01-06-2018 00:43:55
36 Tweet
319 Followers
328 Following
Nice study in JAMA. What’s our strategy at NU? Michael Angarone @NUPulmCritCare NU Internal Medicine Northwestern Feinberg School of Medicine Effect of Piperacillin-Tazobactam vs Meropenem in Escherichia coli or Klebsiella pneumoniae Infection ja.ma/2OatBVp